Evaluation of the Prevalence of Anti-infective Drug Compliance in Pediatric Patients Hospitalized at Nimes University Hospital After Return Home
PEDIAOBST
2 other identifiers
observational
75
1 country
1
Brief Summary
Nowadays, resistance to anti-infectives has become a global public health problem and its increased prevalence threatens human health. To date, few studies have focused on drug compliance in the paediatric population and it varies according to the pathology This drug adherence in the paediatric population is directly linked to outpatient care by the parents or the child's immediate family. In addition, there are no studies on adherence to antibiotics prescribed at the end of hospitalization in the paediatric population. In this context, it seems urgent to seek an intervention capable of leading to responsible and appropriate use of antibiotics in order to improve efficiency in the drug management of acute paediatric infections. This pilot study would characterize pediatric patients and determine the compliance rate in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 4, 2018
CompletedFirst Submitted
Initial submission to the registry
July 1, 2019
CompletedFirst Posted
Study publicly available on registry
July 5, 2019
CompletedDecember 16, 2025
December 1, 2025
2 months
July 1, 2019
December 9, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of patients observing anti-infectives
2018
Secondary Outcomes (1)
Rehospitalization rates / emergency visits related to worsening infection
2018
Other Outcomes (4)
Rate of observing patients who have recovered their anti-infective treatment
2018
Rate of observing patients who have taken anti-infective treatment as prescribed
2018
Sociodemographic and clinical characteristics
2018
- +1 more other outcomes
Eligibility Criteria
The patients included in the study are patients under 16 years of age (\< 16 years of age) admitted to full hospitalization in the paediatric units
You may qualify if:
- The patient is under 16 years of age (\< 16 years of age).
- The patient is admitted to a full hospitalization in one of the 2 paediatric units of the University Hospital of Nîmes.
- The patient is discharged with a prescription for anti-infectives to be taken at home, for a maximum of 30 days.
- The patient and the holder of parental authority are available for a follow-up of 1 month after discharge from hospital.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Nimes
Nîmes, 30029, France
Related Publications (1)
Warembourg M, Lonca N, Filleron A, Tran TA, Knight M, Janes A, Soulairol I, Leguelinel-Blache G. Assessment of anti-infective medication adherence in pediatric outpatients. Eur J Pediatr. 2020 Sep;179(9):1343-1351. doi: 10.1007/s00431-020-03605-8. Epub 2020 Mar 5.
PMID: 32140853RESULT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2019
First Posted
July 5, 2019
Study Start
March 6, 2018
Primary Completion
May 4, 2018
Study Completion
May 4, 2018
Last Updated
December 16, 2025
Record last verified: 2025-12